entertainment -WSS

entertainment

author：focus 2025-09-03 14:43:13 - browse：45684

Representative fluorescent multiplex immunohistochemistry colorful staining of healthy human colon. -- cancer coverage from STAT — Staining reveals different immune cells in a healthy human colon. Courtesy Olivia Newton-John Cancer Research institute

Within the linings of our guts, immune cells patrol like sentries on a castle wall. These cells, called intraepithelial T lymphocytes, are constantly probing the cells of the gut barrier for signs of disease, killing any cells that appear suspect due to infections or cancer mutations.

A new paper published in Science Immunologyon Friday suggests that a subtype of T cells called gamma-delta T cells may be key to that process — and that a protein known as TCF-1 is central to controlling their actions. The work, led by Australian researchers, helps unlock the long underappreciated role of these cells in cancer defense and could open new directions for developing immunotherapies for colorectal cancer, immunologists said.

Gamma-delta T cells have been “largely understudied” compared to their immune counterparts, alpha-beta T cells, said Ana Carrizosa Anderson, a cancer researcher at Harvard University who did not work on the study. “This study certainly helps cement the role of gamma-delta T cells in colon malignancy,” she said. “I think it provides a foundation for building understanding of some basic biology or some therapeutic approaches.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Free speech concerns arise in wake of journal editor Eisen's firing

entertainment

knowledge

WSS

Will an HIV vaccine ever be a reality?

CRISPR base editing slashes cholesterol levels in monkeys

Don't let 'shelved assets' gather dust. Make them into new lifesaving drugs

Medicare solvency divides Republicans at the presidential debate

What will Novo Nordisk's VC do with its influx of cash?

Sanofi CEO defends move to abandon profit guidance, boost research

focus

entertainment

Wikipedia

Medicare proposal to cover medical devices draws a mixed reaction

A clever new way to fix Medicaid and graduate medical education

Continuity nursing helped my family in our darkest PICU moments

With Roe v Wade overturned, abortion providers work to adapt

ChatGPT in medicine: STAT answers readers' burning questions

10 million people disenrolled from Medicaid over past six months

How to save PrEP access — and even expand it

WHO recommends second malaria vaccine

In age of alternative facts, a scholarly course on calling out crap

UCSF medical school apologizes for unethical prisoner experiments

focus

FDA approves potent Eli Lilly obesity drug, Zepbound

FDA approves Recor Medical high blood pressure device

Diversify hospital leadership teams to protect BIPOC patient health

What we owe ALS patients — and why one company fell short

Will an HIV vaccine ever be a reality?

Medicare will require more price transparency from hospitals

knowledge

entertainment

knowledge

entertainment